Oramed Pharmaceuticals ORMP Estimates

NASDAQ ORMP
$4.78 -0.01 (-0.21%)
As of: Aug 20, 2026 · 3:59 PM EDT

Detailed analyst consensus, revenue, and earnings forecasts vs reported data.

Quarterly Revenue Estimates

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26
Reported (Actual) 0.000.000.002.00 M--0.000.00---
High Estimate 275,327.400.000.000.000.000.000.00-0.000.000.00
Low Estimate 238,517.600.000.000.000.000.000.00-0.000.000.00
Consensus Estimate 256,922.500.000.000.000.000.000.00-0.000.000.00

Earnings Per Share (EPS) Estimates

Metric Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 0.22-0.48-0.25-0.190.321.160.000.91--------
High Estimate 0.010.01-0.02-0.01-0.04-0.04-0.06-0.500.590.480.33-0.25-0.38-0.360.85
Low Estimate 0.010.01-0.02-0.01-0.04-0.04-0.08-0.420.530.400.31-0.29-0.42-0.440.79
Consensus Estimate 0.010.01-0.02-0.01-0.04-0.04-0.07-0.460.560.440.32-0.27-0.40-0.400.82